SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an.
/PRNewswire/ SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an.
SpliceBio Raises $57 Million to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Vivet Therapeutics ("Vivet"), a clinical-stage biotechnology company, and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration.